Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder
- PMID: 22005598
- PMCID: PMC3253885
- DOI: 10.1016/j.pbb.2011.09.015
Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder
Abstract
Functional genomics and proteomics approaches are being employed to evaluate gene and encoded protein expression changes with the tacit goal to find novel _targets for drug discovery. Genome-wide association studies (GWAS) have attempted to identify valid candidate genes through single nucleotide polymorphism (SNP) analysis. Furthermore, microarray analysis of gene expression in brain regions and discrete cell populations has enabled the simultaneous quantitative assessment of relevant genes. The ability to associate gene expression changes with neuropsychiatric disorders, including bipolar disorder (BP), and their response to therapeutic drugs provides a novel means for pharmacotherapeutic interventions. This review summarizes gene and pathway _targets that have been identified in GWAS studies and expression profiling of human postmortem brain in BP, with an emphasis on glutamate receptors (GluRs). Although functional genomic assessment of BP is in its infancy, results to date point towards a dysregulation of GluRs that bear some similarity to schizophrenia (SZ), although the pattern is complex, and likely to be more complementary than overlapping. The importance of single population expression profiling of specific neurons and intrinsic circuits is emphasized, as this approach provides informative gene expression profile data that may be underappreciated in regional studies with admixed neuronal and non-neuronal cell types.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder.Am J Med Genet B Neuropsychiatr Genet. 2020 Apr;183(3):181-194. doi: 10.1002/ajmg.b.32775. Epub 2019 Dec 24. Am J Med Genet B Neuropsychiatr Genet. 2020. PMID: 31872970
-
Postmortem brain tissue as an underutilized resource to study the molecular pathology of neuropsychiatric disorders across different ethnic populations.Neurosci Biobehav Rev. 2019 Jul;102:195-207. doi: 10.1016/j.neubiorev.2019.04.015. Epub 2019 Apr 24. Neurosci Biobehav Rev. 2019. PMID: 31028758 Free PMC article. Review.
-
A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.Schizophr Res. 2009 Apr;109(1-3):86-9. doi: 10.1016/j.schres.2009.01.022. Epub 2009 Mar 4. Schizophr Res. 2009. PMID: 19264453 Free PMC article.
-
Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals.Psychol Med. 2015;45(12):2557-69. doi: 10.1017/S0033291715000483. Epub 2015 Mar 30. Psychol Med. 2015. PMID: 25817407 Free PMC article.
-
Comprehensive gene expression analysis in bipolar disorder.Can J Psychiatry. 2007 Dec;52(12):763-71. doi: 10.1177/070674370705201203. Can J Psychiatry. 2007. PMID: 18186176 Review.
Cited by
-
Sensorimotor Gating in Depressed and Euthymic Patients with Bipolar Disorder: Analysis on Prepulse Inhibition of Acoustic Startle Response Stratified by Gender and State.Front Psychiatry. 2018 Apr 18;9:123. doi: 10.3389/fpsyt.2018.00123. eCollection 2018. Front Psychiatry. 2018. PMID: 29720950 Free PMC article.
-
The penalty of stress - Epichaperomes negatively reshaping the brain in neurodegenerative disorders.J Neurochem. 2021 Dec;159(6):958-979. doi: 10.1111/jnc.15525. Epub 2021 Oct 31. J Neurochem. 2021. PMID: 34657288 Free PMC article. Review.
-
Systems biology, bioinformatics, and biomarkers in neuropsychiatry.Front Neurosci. 2012 Dec 24;6:187. doi: 10.3389/fnins.2012.00187. eCollection 2012. Front Neurosci. 2012. PMID: 23269912 Free PMC article.
-
Increased gene expression of FOXP1 in patients with autism spectrum disorders.Mol Autism. 2013 Jul 1;4(1):23. doi: 10.1186/2040-2392-4-23. Mol Autism. 2013. PMID: 23815876 Free PMC article.
-
Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning.Dev Neurobiol. 2015 Jan;75(1):93-108. doi: 10.1002/dneu.22212. Epub 2014 Jul 22. Dev Neurobiol. 2015. PMID: 25045015 Free PMC article.
References
-
- Altar CA, Martin A, Thurkauf A. Antipsychotic Agents. In: Abraham DJ, editor. Burger's Medicinal Chemistry and Drug Discovery. Hoboken: Wiley & Sons; 2003. pp. 599–672.
-
- Avramopoulos D, Lasseter VK, Fallin MD, Wolyniec PS, McGrath JA, Nestadt G, Valle D, Pulver AE. Stage II follow-up on a linkage scan for bipolar disorder in the Ashkenazim provides suggestive evidence for chromosome 12p and the GRIN2B gene. Genet Med. 2007;9:745–751. - PubMed
-
- Bachmann RF, Schloesser RJ, Gould TD, Manji HK. Mood stabilizers _target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol. 2005;32:173–202. - PubMed